If your chronic inflammatory demyelinating polyneuropathy (CIDP) treatment has hit a plateau, new options like FcRn ...

CARLSBAD, Calif., Dec. 21, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (IONS) (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved Ionis and AstraZeneca's ...

Learn the key differences between CIDP and GBS, including causes, onset, and treatments, to ensure you get the correct diagnosis.

TEGSEDI is first antisense oligonucleotide medicine available to patients in Portugal for at-home subcutaneous injection BOSTON, June 1, 2020 /PRNewswire/ -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), a ...

– EU approval based on NEURO-TTRansform Phase 3 results showing WAINZUA demonstrated consistent and sustained benefit improving neuropathy impairment and quality of life versus placebo – CARLSBAD, ...

StemWave acoustic wave therapy offers a non-invasive alternative to traditional peripheral neuropathy treatments, with clinical data from Mercy Family Health showing approximately 85% of patients ...

Add Yahoo as a preferred source to see more of our stories on Google. Your nervous system is a key force behind so many important bodily functions. But when your peripheral nerves—those found outside ...

Dr. Lucas Brown, DAOM, LAc with Rosedale Acupuncture and Wellness spoke with Studio 512 about offering help to people who are experiencing peripheral neuropathy as a side effect of chemotherapy ...

Albuquerque Acupuncture and Integrative Medicine is a local clinic specializing in treating complex chronic illnesses such as neuropathy and auto-immune disease. At the helm is Doctor Andrea Brogdon.

Patients receiving chemotherapy-induced peripheral neuropathy experience persistent, clinically significant symptoms months after treatment.

If you or a loved one are living with hereditary ATTR amyloidosis with cardiomyopathy (hATTR-CM), you are likely well-acquainted with the challenges of heart health. You know the fatigue, the ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Ionis’ WAINUA™ (eplontersen) has been approved in the US for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in ...